
Boston Medical Sciences
Developer of a non-invasive colorectal cancer detection platform designed to improve patient outcomes by leveraging data for decision-making. The company's platform utilizes artificial intelligence to...
Valuation
$31M
Latest known
Share Price
N/A
Total Raised
$9.2M
Last Round
N/A